Febrile neutropenia is a serious side effect of chemotherapy. Colony-stimulating factors (CSFs) are used for primary and secondary treatment in patients with grade 4 neutropenia. The use of CSFs is expensive and accompanied by side effects. In the current study, LifeMel Honey (LMH) was administered to prevent neurotropenia and to reduce the need for CSFs in patients treated with chemotherapy.